Besides SjD, the FDA has granted FTD to nipocalimab in three other indications, hemolytic disease of the fetus and newborn ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first FcRn blocker ever ...

The administration of darbepoetin to preterm infants influenced erythropoiesis in a manner relevant to hemolytic disease of the fetus and newborn (HDFN), a condition in which alloimmune destruction of ...

Untreated cases of HDFN can cause progressive fetal anemia, putting the fetus at risk ... Double trouble: a baby with concurrent hemolytic disease of the fetus and newborn and neonatal alloimmune ...

and warm autoimmune hemolytic anemia (wAIHA) in July 2019, gMG in December 2021 and fetal neonatal alloimmune thrombocytopenia (FNAIT) in March 2024 and Sjögren’s disease (SjD) in March 2025. U.S. FDA ...

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...

July 25, 2024 — In a rigorous medical records study covering tens of thousands of patients, researchers conclude that some patients with preoperative anemia have better outcomes if they get iron ...

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. Medical history made at Cohen Children's Medical ...

Considering taking supplements to treat hemolytic anemia? Below is a list of common natural remedies used to treat or reduce the symptoms of hemolytic anemia. Follow the links to read common uses ...

For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.